News articles about Physicians Realty Trust (NYSE:DOC) have been trending positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Physicians Realty Trust earned a media sentiment score of 0.30 on Accern’s scale. Accern also assigned news coverage about the real estate investment trust an impact score of 46.5290159134945 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- Analysts Expect Physicians Realty Trust (DOC) Will Post Quarterly Sales of $104.19 Million (americanbankingnews.com)
- Is Physicians Realty Trust (NYSE:DOC) Growing Their 0.024077 Earnings? (baycityobserver.com)
- Breathtaking Stocks: VEREIT, Inc. (NYSE:VER), Physicians Realty Trust (NYSE:DOC), Restaurant Brands International … (thestreetpoint.com)
- Physicians Realty Trust (NYSE:DOC) Charts Reveal Positive Trend (cantoncaller.com)
- Pulling Back the Curtain on Physicians Realty Trust (NYSE:DOC)’s Quant Signals as ROE Reaches 0.017831 (zeelandpress.com)
Physicians Realty Trust stock traded down $0.01 on Friday, reaching $17.49. The company’s stock had a trading volume of 1,148,500 shares, compared to its average volume of 1,643,912. The firm has a market cap of $3.18 billion, a P/E ratio of 16.78, a P/E/G ratio of 4.11 and a beta of 0.45. Physicians Realty Trust has a twelve month low of $14.13 and a twelve month high of $19.07. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.16 and a current ratio of 1.16.
DOC has been the topic of several recent research reports. TheStreet raised Physicians Realty Trust from a “c+” rating to a “b” rating in a report on Friday, August 3rd. Royal Bank of Canada reissued a “buy” rating and set a $18.00 price objective on shares of Physicians Realty Trust in a report on Tuesday, August 7th. Zacks Investment Research raised Physicians Realty Trust from a “hold” rating to a “buy” rating and set a $19.00 price target on the stock in a research note on Monday, August 6th. B. Riley boosted their price target on Physicians Realty Trust from $17.00 to $18.00 and gave the company a “buy” rating in a research note on Monday, August 6th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $18.00 price target on shares of Physicians Realty Trust in a research note on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $17.89.
Physicians Realty Trust Company Profile
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.
Featured Story: How Important is Technical Analysis of Stocks
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.